TRCT
ASLN

Tower Research Capital (TRC)’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Tower Research Capital (TRC)’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5
Closed – – 6715
2021
Q4 		$0 Sell
5
-21
-81% -$1.26K ﹤0.01% 6699
2021
Q3 		$2K Buy
+26
New +$2.96K ﹤0.01% 5321
2019
Q3 		– Sell
-7
Closed -$1K – 4612
2019
Q2 		$1K Buy
+7
New +$1.03K ﹤0.01% 3513

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Tower Research Capital (TRC)'s ASLN Position: Q1 2022 in Review

Tower Research Capital (TRC) sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2022, closing a stake of 5 shares.

Tower Research Capital (TRC) first reported a position in ASLN in Q2 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q1 2022.

  • Tower Research Capital (TRC) reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2022.
  • Tower Research Capital (TRC) first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2019 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $2K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.